Comac Medical, a leading full-service Contract Research Organization (CRO) in Central and Eastern Europe, announced the appointment of a new CEO and Board Chair and the launch of an international expansion initiative.
Leadership Appointments
Dr. Chris Smyth has been appointed as Chief Executive Officer, effective 1st September. Based in the UK, Dr. Smyth brings over two decades of executive leadership in global CROs and biotech-focused clinical research. Most recently, he served as President of ICON Biotech, and prior to that, held multiple senior roles at IQVIA Biotech including President and COO.
Comac Medical has also established a new Supervisory Board, chaired by Neil Ferguson. Mr. Ferguson is an experienced global commercial leader with over 35 years in the healthcare and pharmaceutical industries, with over 25 years in the outsourced services sector, including Syneos Health and Quintiles, where he held senior roles driving significant revenue growth and operational scale. Mr. Ferguson will lead the Supervisory Board consisting of Comac Medical's founder and Honorary Chairman Dr. Milen Vrabevski and EdgeCap representatives Dr. Günter Schmid, Christopher Backes and Kristjan Piilmann.
Today's appointments mark a significant milestone for Comac Medical as it enters its next phase of development, building upon the recent additions of two seasoned industry leaders based in Germany, Christian Buhlmann as Chief Commercial Officer and Peter Windisch as Chief Operations Officer.
International Expansion
Comac Medical has established local entities and teams in the United States, Germany, and the United Kingdom to supplement the strong presence Comac Medical already has in Central and Eastern Europe. Dedicated business development teams have been launched in those countries, including on the East and West Coasts of the US, to support biotech and pharma clients in key innovation hubs.
In parallel to its organic expansion, Comac Medical will continue its targeted M&A strategy with the goal of becoming the leading pan-European full-service CRO for biotech and biopharma customers.
Comments powered by CComment